Works matching IS 10837159 AND DT 2024 AND VI 29 AND IP 8

Results: 30

Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 690, doi. 10.1093/oncolo/oyae178
By:
- Hatoum, Hassan;
- Rosemurgy, Alexander;
- Bastidas, J Augusto;
- Zervos, Emmanuel;
- Muscarella, Peter;
- Edil, Barish H;
- Cynamon, Jacob;
- Johnson, D Thor;
- Thomas, Christopher;
- Swinson, Bradley M;
- Nordgren, Aaron;
- Vitulli, Paul;
- Nutting, Charles;
- Gipson, Matthew;
- Tsobanoudis, Alex;
- Agah, Ramtin
Publication type:
Article
Insights into the performance of PREDICT tool in a large Mainland Chinese breast cancer cohort: a comparative analysis of versions 3.0 and 2.2.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e976, doi. 10.1093/oncolo/oyae164
By:
- Chen, Endong;
- Chen, Chen;
- Chen, Yingying;
- You, Jie;
- Jin, Chun;
- Huang, Zhenxuan;
- Zhang, Jiayi;
- Wang, Qingxuan;
- Cai, Yefeng;
- Hu, Xiaoqu;
- Li, Quan
Publication type:
Article
PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 725, doi. 10.1093/oncolo/oyae163
By:
- Mohan, Arathi;
- Quingalahua, Elit;
- Gunchick, Valerie;
- Paul, Simi;
- Kumar-Sinha, Chandan;
- Crysler, Oxana;
- Zalupski, Mark M;
- Sahai, Vaibhav
Publication type:
Article
Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 716, doi. 10.1093/oncolo/oyae156
By:
- Moore, Casey;
- Naraine, Isabel;
- Zhang, Tian
Publication type:
Article
FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 667, doi. 10.1093/oncolo/oyae151
By:
- Mehta, Gautam U;
- Vellanki, Paz J;
- Ren, Yi;
- Amatya, Anup K;
- Mishra-Kalyani, Pallavi S;
- Pan, Lili;
- Zirkelbach, Jeanne F;
- Pan, Yuzhuo;
- Liu, Jiang;
- Aungst, Stephanie L;
- Miller, Claudia P;
- Shah, Mirat;
- Rahman, Nam Atiqur;
- Theoret, Marc;
- Kluetz, Paul;
- Pazdur, Richard;
- Beaver, Julia A;
- Singh, Harpreet
Publication type:
Article
Understanding variants of unknown significance and classification of genomic alterations.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 658, doi. 10.1093/oncolo/oyae149
By:
- Pavlick, Dean C;
- Frampton, Garrett M;
- Ross, Jeffrey R
Publication type:
Article
Unleashing the power of clinical trial data: a proposal for enhancing informed consent and data sharing.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 651, doi. 10.1093/oncolo/oyae138
By:
- Trippa, Lorenzo;
- Khozin, Sean
Publication type:
Article
Lifileucel: FDA-approved T-cell therapy for melanoma.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 648, doi. 10.1093/oncolo/oyae136
By:
- Kwong, Mei Li M;
- Yang, James C
Publication type:
Article
Variants of uncertain significance in precision oncology: nuance or nuisance?
Published in:
Oncologist, 2024, v. 29, n. 8, p. 641, doi. 10.1093/oncolo/oyae135
By:
- Mellgard, George S;
- Atabek, Zoey;
- LaRose, Meredith;
- Kastrinos, Fay;
- Bates, Susan E
Publication type:
Article
Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1061, doi. 10.1093/oncolo/oyae132
By:
- Xu, Shuaishuai;
- Cao, Linping;
- Chen, Ruyin;
- Ye, Chanqi;
- Li, Qiong;
- Jiang, Qi;
- Yan, Feifei;
- Wan, Mingyu;
- Zhang, Xiaochen;
- Ruan, Jian
Publication type:
Article
Has the blood-brain barrier finally been busted?
Published in:
Oncologist, 2024, v. 29, n. 8, p. 645, doi. 10.1093/oncolo/oyae131
By:
- Stewart, David J
Publication type:
Article
Optimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety analyses from the EPOCH study.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 681, doi. 10.1093/oncolo/oyae128
By:
- Salem, Riad;
- Garin, Etienne;
- Boucher, Eveline;
- Fowers, Kirk;
- Lam, Marnix;
- Padia, Siddharth;
- Harris, William
Publication type:
Article
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1094, doi. 10.1093/oncolo/oyae127
By:
- Zhu, Xiaolin;
- Chan, Emily;
- Turski, Michelle L;
- Mendez, Carlos Espinosa;
- Hsu, Sarah C;
- Kumar, Vipul;
- Shipp, Chase;
- Jindal, Tanya;
- Chang, Kevin;
- Onodera, Courtney;
- Devine, W Patrick;
- Grenert, James P;
- Stohr, Bradley A;
- Ding, Chien-Kuang Cornelia;
- Stachler, Matthew D;
- Quigley, David A;
- Feng, Felix Y;
- Chu, Carissa E;
- Porten, Sima P;
- Chou, Jonathan
Publication type:
Article
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 707, doi. 10.1093/oncolo/oyae125
By:
- Belli, Carmen;
- Bielo, Luca Boscolo;
- Repetto, Matteo;
- Crimini, Edoardo;
- Scalia, Raimondo;
- Diana, Anna;
- Orefice, Jessica;
- Ascione, Liliana;
- Pellizzari, Gloria;
- Fusco, Nicola;
- Barberis, Massimo;
- Daniele, Bruno;
- Guerini-Rocco, Elena;
- Curigliano, Giuseppe
Publication type:
Article
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 723, doi. 10.1093/oncolo/oyae119
By:
- Nelson, Marie V;
- Kim, AeRang;
- Williams, P Mickey;
- Roy-Chowdhuri, Sinchita;
- Patton, David R;
- Coffey, Brent D;
- Reid, Joel M;
- Piao, Jin;
- Saguilig, Lauren;
- Alonzo, Todd A;
- Berg, Stacey L;
- Ramirez, Nilsa C;
- Jaju, Alok;
- Fox, Elizabeth;
- Weigel, Brenda J;
- Hawkins, Douglas S;
- Mooney, Margaret M;
- Takebe, Naoko;
- Tricoli, James V;
- Janeway, Katherine A
Publication type:
Article
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitors.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 721, doi. 10.1093/oncolo/oyae117
By:
- Dayyani, Farshid;
- Chao, Joseph;
- Lee, Fa-Chyi;
- Taylor, Thomas H;
- Neumann, Kristen;
- Cho, May T
Publication type:
Article
Frequency of HLA-A*02:01 in the Brazilian population and its impact on uveal melanoma systemic treatment.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1098, doi. 10.1093/oncolo/oyae112
By:
- Melo, Andreia Cristina de;
- Lucena, Evandro;
- Oliveira, Danielli Cristina Muniz de;
- Viola, João P B
Publication type:
Article
Understanding variants of unknown significance: the computational frontier.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 653, doi. 10.1093/oncolo/oyae103
By:
- Fu, Xi;
- Rabadan, Raul
Publication type:
Article
Correction to: Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.
Published in:
2024
Publication type:
Correction Notice
A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1012, doi. 10.1093/oncolo/oyae073
By:
- Li, Jin;
- Wang, Zhiqiang;
- Zhong, Haijun;
- He, Yifu;
- Zhang, Chen;
- Niu, Zuoxing;
- Yang, Shujun;
- Zhang, Tao;
- Zhu, Liangjun;
- Shu, Yongqian;
- Gao, Yong;
- Peng, Jianjun;
- Song, Yan;
- Li, Jian;
- Yuan, Ying;
- Zhang, Haibo;
- Yu, Gengsheng;
- Hua, Yunqi;
- Xiao, Jianjun;
- Fu, Jianfei
Publication type:
Article
EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer and their prognostic significance.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1051, doi. 10.1093/oncolo/oyae076
By:
- Kim, Yeseul;
- Jee, Seungyun;
- Kim, Hyunsung;
- Paik, Seung Sam;
- Choi, Dongho;
- Yoo, Su Hyun;
- Shin, Su-Jin
Publication type:
Article
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 699, doi. 10.1093/oncolo/oyae072
By:
- Saad, Eddy;
- Gebrael, Georges;
- Semaan, Karl;
- Eid, Marc;
- Saliby, Renée Maria;
- Labaki, Chris;
- Sayegh, Nicolas;
- Wells, J Connor;
- Takemura, Kosuke;
- Ernst, Matthew Scott;
- Lemelin, Audreylie;
- Basappa, Naveen S;
- Wood, Lori A;
- Powles, Thomas;
- Ernst, D Scott;
- Lalani, Aly-Khan A;
- Agarwal, Neeraj;
- Xie, Wanling;
- Heng, Daniel Y C;
- Choueiri, Toni K
Publication type:
Article
Rational treatment options for T1/2N0M0 squamous cell carcinoma of the anal canal: a population-based study combined with external validation.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1003, doi. 10.1093/oncolo/oyae068
By:
- Shao, Xue;
- Zhang, Qiulei;
- Huo, Ying;
- Lu, Chang
Publication type:
Article
Comorbidity profiling identifies potential subtype of elderly patients with nasopharyngeal carcinoma.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1020, doi. 10.1093/oncolo/oyae063
By:
- Li, Ying;
- Pan, Yuhui;
- Huang, Zongwei;
- Wu, Lishui;
- Wu, Wenxi;
- Xu, Siqi;
- Chen, Zihan;
- Chen, Xin;
- Lu, Jun;
- Qiu, Sufang
Publication type:
Article
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers.
Published in:
Oncologist, 2024, v. 29, n. 8, p. 672, doi. 10.1093/oncolo/oyae061
By:
- Shariff, Bushra;
- Barnett, Reagan M;
- Dayyani, Farshid;
- Maron, Steven B;
- Mcgriskin, Rory;
- Klempner, Samuel;
- Donderici, Elifnur Yay;
- Zhang, Nicole;
- Masannat, Jude;
- Drusbosky, Leylah M;
- Mehta, Rutika
Publication type:
Article
Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter Program.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e967, doi. 10.1093/oncolo/oyae057
By:
- Zhou, Ke;
- Bellanger, Martine;
- Crivelli, Louise;
- Laham, Sandy;
- Huet, Charlotte;
- Abadie, Caroline
Publication type:
Article
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Published in:
Oncologist, 2024, v. 29, n. 8, p. e997, doi. 10.1093/oncolo/oyae056
By:
- Sunakawa, Yu;
- Sakamoto, Yasuhiro;
- Kawabata, Ryohei;
- Ishiguro, Atsushi;
- Akamaru, Yusuke;
- Kito, Yosuke;
- Takahashi, Masazumi;
- Matsuyama, Jin;
- Yabusaki, Hiroshi;
- Makiyama, Akitaka;
- Suzuki, Takahisa;
- Tsuda, Masahiro;
- Yasui, Hisateru;
- Hihara, Jun;
- Takeno, Atsushi;
- Inoue, Eisuke;
- Ichikawa, Wataru;
- Fujii, Masashi
Publication type:
Article
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1041, doi. 10.1093/oncolo/oyae032
By:
- Wang, Lei;
- Feng, Jin-Kai;
- Lu, Chong-De;
- Wu, Jia-Yi;
- Zhou, Bin;
- Wang, Kang;
- Wei, Xu-Biao;
- Liang, Chao;
- Zhou, Hong-Kun;
- Shi, Jie;
- Guo, Wei-Xing;
- Lau, Wan Yee;
- Yan, Mao-Lin;
- Cheng, Shu-Qun
Publication type:
Article
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e984, doi. 10.1093/oncolo/oyae028
By:
- Mack, Philip C;
- Keller-Evans, Rachel B;
- Li, Gerald;
- Lofgren, Katherine T;
- Schrock, Alexa B;
- Trabucco, Sally E;
- Allen, Justin M;
- Tolba, Khaled;
- Oxnard, Geoffrey R;
- Huang, Richard S P
Publication type:
Article
Meta-Analysis of 49 Roche Oncology Trials Comparing Blinded Independent Central Review (BICR) and Local Evaluation to Assess the Value of BICR.
Published in:
Oncologist, 2024, v. 29, n. 8, p. e1073, doi. 10.1093/oncolo/oyad012
By:
- Lian, Qinshu;
- Fredrickson, Jill;
- Boudier, Kamila;
- Rothkegel, Christiane;
- Hilton, Magalie;
- Hillebrecht, Alexander;
- McDonald, Andrew;
- Xu, Na
Publication type:
Article